Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.

"Supported by grants from the Keating Foundation, Woodward Crohn’s and Colitis Foundation and Seattle Children’s Center for Clinical and Translational Research Academic Enrichment Fund. This publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000423. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

"This is a multicenter, open-label study designed to determine tolerability, preliminary safety, and potential efficacy of the SCD in pediatric patients with IBD. The protocol was approved by the Institutional Review Board of Seattle Children’s Hospital and Children’s Center for Digestive Health Care. All patients/participants provided written informed consent or assent. The study was registered with ClinicalTrials.gov (number: NCT02213835). Study participants were recruited from Seattle Children’s Hospital and Children’s Center for Digestive Health Care outpatient gastroenterology clinics."